nodes	percent_of_prediction	percent_of_DWPC	metapath
Prazosin—SLC22A3—coronary artery disease	0.296	1	CbGaD
Prazosin—ORM1—Penbutolol—coronary artery disease	0.0544	0.134	CbGbCtD
Prazosin—ORM1—Pitavastatin—coronary artery disease	0.0476	0.117	CbGbCtD
Prazosin—HTR1A—Penbutolol—coronary artery disease	0.0355	0.0873	CbGbCtD
Prazosin—ABCG2—Telmisartan—coronary artery disease	0.029	0.0714	CbGbCtD
Prazosin—ABCG2—Pitavastatin—coronary artery disease	0.029	0.0714	CbGbCtD
Prazosin—ABCG2—Ezetimibe—coronary artery disease	0.0214	0.0527	CbGbCtD
Prazosin—ABCG2—Rosuvastatin—coronary artery disease	0.0214	0.0527	CbGbCtD
Prazosin—ABCG2—Pravastatin—coronary artery disease	0.0195	0.0479	CbGbCtD
Prazosin—ABCB1—Ticagrelor—coronary artery disease	0.0194	0.0477	CbGbCtD
Prazosin—ABCB1—Perindopril—coronary artery disease	0.012	0.0295	CbGbCtD
Prazosin—ABCB1—Clopidogrel—coronary artery disease	0.012	0.0295	CbGbCtD
Prazosin—KCNH2—purkinje fiber—coronary artery disease	0.0117	0.421	CbGeAlD
Prazosin—ABCB1—Telmisartan—coronary artery disease	0.0105	0.0258	CbGbCtD
Prazosin—ABCB1—Pitavastatin—coronary artery disease	0.0105	0.0258	CbGbCtD
Prazosin—ABCB1—Lisinopril—coronary artery disease	0.00993	0.0244	CbGbCtD
Prazosin—ABCB1—Enalapril—coronary artery disease	0.00993	0.0244	CbGbCtD
Prazosin—ABCB1—Timolol—coronary artery disease	0.00844	0.0208	CbGbCtD
Prazosin—ABCB1—Ezetimibe—coronary artery disease	0.00772	0.019	CbGbCtD
Prazosin—ABCB1—Acetylsalicylic acid—coronary artery disease	0.00752	0.0185	CbGbCtD
Prazosin—ABCB1—Captopril—coronary artery disease	0.00743	0.0183	CbGbCtD
Prazosin—ABCB1—Simvastatin—coronary artery disease	0.00718	0.0177	CbGbCtD
Prazosin—ABCB1—Pravastatin—coronary artery disease	0.00702	0.0173	CbGbCtD
Prazosin—ABCB1—Lovastatin—coronary artery disease	0.00702	0.0173	CbGbCtD
Prazosin—ABCB1—Atorvastatin—coronary artery disease	0.0064	0.0157	CbGbCtD
Prazosin—KCNH2—endocardium—coronary artery disease	0.00602	0.217	CbGeAlD
Prazosin—ABCB1—Losartan—coronary artery disease	0.00585	0.0144	CbGbCtD
Prazosin—MT3—heart—coronary artery disease	0.00152	0.0547	CbGeAlD
Prazosin—HTR1D—artery—coronary artery disease	0.00122	0.0438	CbGeAlD
Prazosin—KCNH2—cardiac ventricle—coronary artery disease	0.000507	0.0182	CbGeAlD
Prazosin—KCNH2—myocardium—coronary artery disease	0.000477	0.0172	CbGeAlD
Prazosin—CYP1A1—cardiac ventricle—coronary artery disease	0.000428	0.0154	CbGeAlD
Prazosin—HTR1D—cardiovascular system—coronary artery disease	0.000423	0.0152	CbGeAlD
Prazosin—ORM1—blood—coronary artery disease	0.000369	0.0133	CbGeAlD
Prazosin—HTR1A—cardiovascular system—coronary artery disease	0.000353	0.0127	CbGeAlD
Prazosin—ADRA1A—heart—coronary artery disease	0.000344	0.0124	CbGeAlD
Prazosin—SLC22A1—blood—coronary artery disease	0.000338	0.0122	CbGeAlD
Prazosin—KCNH2—heart—coronary artery disease	0.000333	0.012	CbGeAlD
Prazosin—ADRA1A—cardiovascular system—coronary artery disease	0.000325	0.0117	CbGeAlD
Prazosin—KCNH2—cardiovascular system—coronary artery disease	0.000314	0.0113	CbGeAlD
Prazosin—ABCG2—heart—coronary artery disease	0.000296	0.0107	CbGeAlD
Prazosin—KCNH2—cardiac atrium—coronary artery disease	0.000285	0.0102	CbGeAlD
Prazosin—CYP1A1—heart—coronary artery disease	0.000281	0.0101	CbGeAlD
Prazosin—ADRA2A—heart—coronary artery disease	0.000262	0.00943	CbGeAlD
Prazosin—ADRA1A—blood—coronary artery disease	0.000257	0.00926	CbGeAlD
Prazosin—KCNH2—blood—coronary artery disease	0.000248	0.00894	CbGeAlD
Prazosin—CYP1A1—cardiac atrium—coronary artery disease	0.00024	0.00865	CbGeAlD
Prazosin—ADRA2A—cardiac atrium—coronary artery disease	0.000224	0.00807	CbGeAlD
Prazosin—ABCG2—blood—coronary artery disease	0.000221	0.00795	CbGeAlD
Prazosin—CYP1A1—blood—coronary artery disease	0.00021	0.00755	CbGeAlD
Prazosin—ADRA2A—blood—coronary artery disease	0.000195	0.00704	CbGeAlD
Prazosin—ABCB1—heart—coronary artery disease	0.000146	0.00526	CbGeAlD
Prazosin—ABCB1—cardiovascular system—coronary artery disease	0.000138	0.00496	CbGeAlD
Prazosin—ABCB1—blood—coronary artery disease	0.000109	0.00392	CbGeAlD
Prazosin—Feeling abnormal—Captopril—coronary artery disease	0.000103	0.000631	CcSEcCtD
Prazosin—Insomnia—Losartan—coronary artery disease	0.000103	0.000631	CcSEcCtD
Prazosin—Rash—Fenofibrate—coronary artery disease	0.000103	0.000631	CcSEcCtD
Prazosin—Dermatitis—Fenofibrate—coronary artery disease	0.000103	0.00063	CcSEcCtD
Prazosin—Loss of consciousness—Timolol—coronary artery disease	0.000103	0.00063	CcSEcCtD
Prazosin—Headache—Fenofibrate—coronary artery disease	0.000102	0.000627	CcSEcCtD
Prazosin—Vision blurred—Lisinopril—coronary artery disease	0.000102	0.000627	CcSEcCtD
Prazosin—Paraesthesia—Losartan—coronary artery disease	0.000102	0.000626	CcSEcCtD
Prazosin—Urticaria—Telmisartan—coronary artery disease	0.000102	0.000626	CcSEcCtD
Prazosin—Vomiting—Clopidogrel—coronary artery disease	0.000102	0.000625	CcSEcCtD
Prazosin—Diarrhoea—Simvastatin—coronary artery disease	0.000102	0.000625	CcSEcCtD
Prazosin—Arthralgia—Ramipril—coronary artery disease	0.000102	0.000624	CcSEcCtD
Prazosin—Fatigue—Furosemide—coronary artery disease	0.000102	0.000623	CcSEcCtD
Prazosin—Body temperature increased—Telmisartan—coronary artery disease	0.000102	0.000623	CcSEcCtD
Prazosin—Dyspnoea—Losartan—coronary artery disease	0.000101	0.000622	CcSEcCtD
Prazosin—Vomiting—Lovastatin—coronary artery disease	0.000101	0.000621	CcSEcCtD
Prazosin—Somnolence—Losartan—coronary artery disease	0.000101	0.00062	CcSEcCtD
Prazosin—Dizziness—Eplerenone—coronary artery disease	0.000101	0.00062	CcSEcCtD
Prazosin—Rash—Clopidogrel—coronary artery disease	0.000101	0.00062	CcSEcCtD
Prazosin—Dermatitis—Clopidogrel—coronary artery disease	0.000101	0.000619	CcSEcCtD
Prazosin—Asthenia—Valsartan—coronary artery disease	0.000101	0.000619	CcSEcCtD
Prazosin—Pain—Furosemide—coronary artery disease	0.000101	0.000618	CcSEcCtD
Prazosin—Constipation—Furosemide—coronary artery disease	0.000101	0.000618	CcSEcCtD
Prazosin—Hypersensitivity—Niacin—coronary artery disease	0.000101	0.000618	CcSEcCtD
Prazosin—Ill-defined disorder—Lisinopril—coronary artery disease	0.000101	0.000617	CcSEcCtD
Prazosin—Discomfort—Ramipril—coronary artery disease	0.000101	0.000617	CcSEcCtD
Prazosin—Asthenia—Olmesartan—coronary artery disease	0.0001	0.000616	CcSEcCtD
Prazosin—Headache—Clopidogrel—coronary artery disease	0.0001	0.000616	CcSEcCtD
Prazosin—Rash—Lovastatin—coronary artery disease	0.0001	0.000616	CcSEcCtD
Prazosin—Dermatitis—Lovastatin—coronary artery disease	0.0001	0.000615	CcSEcCtD
Prazosin—Feeling abnormal—Perindopril—coronary artery disease	0.0001	0.000613	CcSEcCtD
Prazosin—Headache—Lovastatin—coronary artery disease	9.98e-05	0.000612	CcSEcCtD
Prazosin—Pruritus—Valsartan—coronary artery disease	9.96e-05	0.00061	CcSEcCtD
Prazosin—Dry mouth—Ramipril—coronary artery disease	9.96e-05	0.00061	CcSEcCtD
Prazosin—Arthralgia—Timolol—coronary artery disease	9.95e-05	0.00061	CcSEcCtD
Prazosin—Vomiting—Ezetimibe—coronary artery disease	9.93e-05	0.000609	CcSEcCtD
Prazosin—Hypersensitivity—Pravastatin—coronary artery disease	9.93e-05	0.000608	CcSEcCtD
Prazosin—Pruritus—Olmesartan—coronary artery disease	9.91e-05	0.000607	CcSEcCtD
Prazosin—Body temperature increased—Captopril—coronary artery disease	9.88e-05	0.000606	CcSEcCtD
Prazosin—Dizziness—Simvastatin—coronary artery disease	9.85e-05	0.000604	CcSEcCtD
Prazosin—Rash—Ezetimibe—coronary artery disease	9.85e-05	0.000604	CcSEcCtD
Prazosin—Dermatitis—Ezetimibe—coronary artery disease	9.84e-05	0.000603	CcSEcCtD
Prazosin—Discomfort—Timolol—coronary artery disease	9.83e-05	0.000603	CcSEcCtD
Prazosin—Asthenia—Niacin—coronary artery disease	9.82e-05	0.000602	CcSEcCtD
Prazosin—Fatigue—Losartan—coronary artery disease	9.81e-05	0.000602	CcSEcCtD
Prazosin—Headache—Ezetimibe—coronary artery disease	9.79e-05	0.0006	CcSEcCtD
Prazosin—Malaise—Lisinopril—coronary artery disease	9.78e-05	0.0006	CcSEcCtD
Prazosin—Oedema—Ramipril—coronary artery disease	9.76e-05	0.000598	CcSEcCtD
Prazosin—Vertigo—Lisinopril—coronary artery disease	9.74e-05	0.000597	CcSEcCtD
Prazosin—Dry mouth—Timolol—coronary artery disease	9.73e-05	0.000597	CcSEcCtD
Prazosin—Constipation—Losartan—coronary artery disease	9.73e-05	0.000597	CcSEcCtD
Prazosin—Pain—Losartan—coronary artery disease	9.73e-05	0.000597	CcSEcCtD
Prazosin—Syncope—Lisinopril—coronary artery disease	9.72e-05	0.000596	CcSEcCtD
Prazosin—Vomiting—Eplerenone—coronary artery disease	9.72e-05	0.000596	CcSEcCtD
Prazosin—Feeling abnormal—Furosemide—coronary artery disease	9.72e-05	0.000596	CcSEcCtD
Prazosin—Nausea—Fenofibrate—coronary artery disease	9.69e-05	0.000594	CcSEcCtD
Prazosin—Pruritus—Niacin—coronary artery disease	9.68e-05	0.000593	CcSEcCtD
Prazosin—Asthenia—Pravastatin—coronary artery disease	9.67e-05	0.000593	CcSEcCtD
Prazosin—Rash—Eplerenone—coronary artery disease	9.64e-05	0.000591	CcSEcCtD
Prazosin—Urticaria—Perindopril—coronary artery disease	9.64e-05	0.000591	CcSEcCtD
Prazosin—Hypersensitivity—Trandolapril—coronary artery disease	9.64e-05	0.000591	CcSEcCtD
Prazosin—Dermatitis—Eplerenone—coronary artery disease	9.63e-05	0.000591	CcSEcCtD
Prazosin—Diarrhoea—Valsartan—coronary artery disease	9.63e-05	0.00059	CcSEcCtD
Prazosin—Shock—Ramipril—coronary artery disease	9.6e-05	0.000589	CcSEcCtD
Prazosin—Hypersensitivity—Enalapril—coronary artery disease	9.6e-05	0.000589	CcSEcCtD
Prazosin—Body temperature increased—Perindopril—coronary artery disease	9.59e-05	0.000588	CcSEcCtD
Prazosin—Palpitations—Lisinopril—coronary artery disease	9.58e-05	0.000587	CcSEcCtD
Prazosin—Diarrhoea—Olmesartan—coronary artery disease	9.58e-05	0.000587	CcSEcCtD
Prazosin—Headache—Eplerenone—coronary artery disease	9.58e-05	0.000587	CcSEcCtD
Prazosin—Oedema—Timolol—coronary artery disease	9.54e-05	0.000585	CcSEcCtD
Prazosin—Pruritus—Pravastatin—coronary artery disease	9.53e-05	0.000584	CcSEcCtD
Prazosin—Loss of consciousness—Lisinopril—coronary artery disease	9.53e-05	0.000584	CcSEcCtD
Prazosin—Nausea—Clopidogrel—coronary artery disease	9.53e-05	0.000584	CcSEcCtD
Prazosin—Tachycardia—Ramipril—coronary artery disease	9.52e-05	0.000584	CcSEcCtD
Prazosin—Vomiting—Simvastatin—coronary artery disease	9.47e-05	0.000581	CcSEcCtD
Prazosin—Hypersensitivity—Telmisartan—coronary artery disease	9.47e-05	0.00058	CcSEcCtD
Prazosin—Nausea—Lovastatin—coronary artery disease	9.46e-05	0.00058	CcSEcCtD
Prazosin—Hyperhidrosis—Ramipril—coronary artery disease	9.43e-05	0.000578	CcSEcCtD
Prazosin—Rash—Simvastatin—coronary artery disease	9.4e-05	0.000576	CcSEcCtD
Prazosin—Dermatitis—Simvastatin—coronary artery disease	9.39e-05	0.000575	CcSEcCtD
Prazosin—Asthenia—Trandolapril—coronary artery disease	9.39e-05	0.000575	CcSEcCtD
Prazosin—Shock—Timolol—coronary artery disease	9.39e-05	0.000575	CcSEcCtD
Prazosin—Feeling abnormal—Losartan—coronary artery disease	9.38e-05	0.000575	CcSEcCtD
Prazosin—Urticaria—Furosemide—coronary artery disease	9.37e-05	0.000574	CcSEcCtD
Prazosin—Diarrhoea—Niacin—coronary artery disease	9.36e-05	0.000574	CcSEcCtD
Prazosin—Asthenia—Enalapril—coronary artery disease	9.35e-05	0.000573	CcSEcCtD
Prazosin—Headache—Simvastatin—coronary artery disease	9.34e-05	0.000572	CcSEcCtD
Prazosin—Body temperature increased—Furosemide—coronary artery disease	9.32e-05	0.000572	CcSEcCtD
Prazosin—Dizziness—Valsartan—coronary artery disease	9.31e-05	0.00057	CcSEcCtD
Prazosin—Nausea—Ezetimibe—coronary artery disease	9.28e-05	0.000569	CcSEcCtD
Prazosin—Dizziness—Olmesartan—coronary artery disease	9.26e-05	0.000568	CcSEcCtD
Prazosin—Pruritus—Trandolapril—coronary artery disease	9.26e-05	0.000567	CcSEcCtD
Prazosin—Arthralgia—Lisinopril—coronary artery disease	9.23e-05	0.000566	CcSEcCtD
Prazosin—Hyperhidrosis—Timolol—coronary artery disease	9.22e-05	0.000565	CcSEcCtD
Prazosin—Asthenia—Telmisartan—coronary artery disease	9.22e-05	0.000565	CcSEcCtD
Prazosin—Pruritus—Enalapril—coronary artery disease	9.22e-05	0.000565	CcSEcCtD
Prazosin—Diarrhoea—Pravastatin—coronary artery disease	9.22e-05	0.000565	CcSEcCtD
Prazosin—Discomfort—Lisinopril—coronary artery disease	9.12e-05	0.000559	CcSEcCtD
Prazosin—Pruritus—Telmisartan—coronary artery disease	9.09e-05	0.000557	CcSEcCtD
Prazosin—Nausea—Eplerenone—coronary artery disease	9.08e-05	0.000557	CcSEcCtD
Prazosin—Dizziness—Niacin—coronary artery disease	9.05e-05	0.000555	CcSEcCtD
Prazosin—Urticaria—Losartan—coronary artery disease	9.04e-05	0.000554	CcSEcCtD
Prazosin—Dry mouth—Lisinopril—coronary artery disease	9.03e-05	0.000554	CcSEcCtD
Prazosin—Body temperature increased—Losartan—coronary artery disease	9e-05	0.000552	CcSEcCtD
Prazosin—Asthenia—Captopril—coronary artery disease	8.97e-05	0.00055	CcSEcCtD
Prazosin—Diarrhoea—Trandolapril—coronary artery disease	8.95e-05	0.000549	CcSEcCtD
Prazosin—Vomiting—Valsartan—coronary artery disease	8.95e-05	0.000549	CcSEcCtD
Prazosin—Diarrhoea—Enalapril—coronary artery disease	8.92e-05	0.000547	CcSEcCtD
Prazosin—Dizziness—Pravastatin—coronary artery disease	8.91e-05	0.000546	CcSEcCtD
Prazosin—Vomiting—Olmesartan—coronary artery disease	8.9e-05	0.000546	CcSEcCtD
Prazosin—Musculoskeletal discomfort—Ramipril—coronary artery disease	8.89e-05	0.000545	CcSEcCtD
Prazosin—Rash—Valsartan—coronary artery disease	8.87e-05	0.000544	CcSEcCtD
Prazosin—Dermatitis—Valsartan—coronary artery disease	8.86e-05	0.000543	CcSEcCtD
Prazosin—Nausea—Simvastatin—coronary artery disease	8.85e-05	0.000543	CcSEcCtD
Prazosin—Oedema—Lisinopril—coronary artery disease	8.85e-05	0.000543	CcSEcCtD
Prazosin—Pruritus—Captopril—coronary artery disease	8.84e-05	0.000542	CcSEcCtD
Prazosin—Rash—Olmesartan—coronary artery disease	8.83e-05	0.000541	CcSEcCtD
Prazosin—Insomnia—Ramipril—coronary artery disease	8.83e-05	0.000541	CcSEcCtD
Prazosin—Dermatitis—Olmesartan—coronary artery disease	8.82e-05	0.000541	CcSEcCtD
Prazosin—Headache—Valsartan—coronary artery disease	8.82e-05	0.00054	CcSEcCtD
Prazosin—Diarrhoea—Telmisartan—coronary artery disease	8.79e-05	0.000539	CcSEcCtD
Prazosin—Headache—Olmesartan—coronary artery disease	8.77e-05	0.000538	CcSEcCtD
Prazosin—Paraesthesia—Ramipril—coronary artery disease	8.76e-05	0.000537	CcSEcCtD
Prazosin—Shock—Lisinopril—coronary artery disease	8.71e-05	0.000534	CcSEcCtD
Prazosin—Asthenia—Perindopril—coronary artery disease	8.71e-05	0.000534	CcSEcCtD
Prazosin—Dyspnoea—Ramipril—coronary artery disease	8.7e-05	0.000533	CcSEcCtD
Prazosin—Vomiting—Niacin—coronary artery disease	8.7e-05	0.000533	CcSEcCtD
Prazosin—Musculoskeletal discomfort—Timolol—coronary artery disease	8.69e-05	0.000533	CcSEcCtD
Prazosin—Hypersensitivity—Furosemide—coronary artery disease	8.69e-05	0.000533	CcSEcCtD
Prazosin—Somnolence—Ramipril—coronary artery disease	8.68e-05	0.000532	CcSEcCtD
Prazosin—Dizziness—Trandolapril—coronary artery disease	8.65e-05	0.00053	CcSEcCtD
Prazosin—Tachycardia—Lisinopril—coronary artery disease	8.64e-05	0.00053	CcSEcCtD
Prazosin—Insomnia—Timolol—coronary artery disease	8.63e-05	0.000529	CcSEcCtD
Prazosin—Rash—Niacin—coronary artery disease	8.63e-05	0.000529	CcSEcCtD
Prazosin—Dermatitis—Niacin—coronary artery disease	8.62e-05	0.000528	CcSEcCtD
Prazosin—Dizziness—Enalapril—coronary artery disease	8.62e-05	0.000528	CcSEcCtD
Prazosin—Pruritus—Perindopril—coronary artery disease	8.58e-05	0.000526	CcSEcCtD
Prazosin—Headache—Niacin—coronary artery disease	8.57e-05	0.000525	CcSEcCtD
Prazosin—Paraesthesia—Timolol—coronary artery disease	8.57e-05	0.000525	CcSEcCtD
Prazosin—Vomiting—Pravastatin—coronary artery disease	8.57e-05	0.000525	CcSEcCtD
Prazosin—Hyperhidrosis—Lisinopril—coronary artery disease	8.56e-05	0.000525	CcSEcCtD
Prazosin—Diarrhoea—Captopril—coronary artery disease	8.55e-05	0.000524	CcSEcCtD
Prazosin—Dyspnoea—Timolol—coronary artery disease	8.51e-05	0.000521	CcSEcCtD
Prazosin—Dizziness—Telmisartan—coronary artery disease	8.5e-05	0.000521	CcSEcCtD
Prazosin—Rash—Pravastatin—coronary artery disease	8.49e-05	0.000521	CcSEcCtD
Prazosin—Dermatitis—Pravastatin—coronary artery disease	8.49e-05	0.00052	CcSEcCtD
Prazosin—Somnolence—Timolol—coronary artery disease	8.48e-05	0.00052	CcSEcCtD
Prazosin—Asthenia—Furosemide—coronary artery disease	8.46e-05	0.000519	CcSEcCtD
Prazosin—Headache—Pravastatin—coronary artery disease	8.44e-05	0.000517	CcSEcCtD
Prazosin—Fatigue—Ramipril—coronary artery disease	8.41e-05	0.000516	CcSEcCtD
Prazosin—Hypersensitivity—Losartan—coronary artery disease	8.39e-05	0.000514	CcSEcCtD
Prazosin—Nausea—Valsartan—coronary artery disease	8.36e-05	0.000512	CcSEcCtD
Prazosin—Pruritus—Furosemide—coronary artery disease	8.35e-05	0.000512	CcSEcCtD
Prazosin—Constipation—Ramipril—coronary artery disease	8.35e-05	0.000512	CcSEcCtD
Prazosin—Nausea—Olmesartan—coronary artery disease	8.32e-05	0.00051	CcSEcCtD
Prazosin—Vomiting—Trandolapril—coronary artery disease	8.32e-05	0.00051	CcSEcCtD
Prazosin—Diarrhoea—Perindopril—coronary artery disease	8.3e-05	0.000509	CcSEcCtD
Prazosin—Vomiting—Enalapril—coronary artery disease	8.28e-05	0.000508	CcSEcCtD
Prazosin—Dizziness—Captopril—coronary artery disease	8.26e-05	0.000507	CcSEcCtD
Prazosin—Rash—Trandolapril—coronary artery disease	8.25e-05	0.000506	CcSEcCtD
Prazosin—Dermatitis—Trandolapril—coronary artery disease	8.24e-05	0.000505	CcSEcCtD
Prazosin—Fatigue—Timolol—coronary artery disease	8.23e-05	0.000504	CcSEcCtD
Prazosin—Rash—Enalapril—coronary artery disease	8.22e-05	0.000504	CcSEcCtD
Prazosin—Dermatitis—Enalapril—coronary artery disease	8.21e-05	0.000503	CcSEcCtD
Prazosin—Headache—Trandolapril—coronary artery disease	8.2e-05	0.000502	CcSEcCtD
Prazosin—Vomiting—Telmisartan—coronary artery disease	8.17e-05	0.000501	CcSEcCtD
Prazosin—Asthenia—Losartan—coronary artery disease	8.17e-05	0.000501	CcSEcCtD
Prazosin—Headache—Enalapril—coronary artery disease	8.16e-05	0.0005	CcSEcCtD
Prazosin—Pain—Timolol—coronary artery disease	8.16e-05	0.0005	CcSEcCtD
Prazosin—Nausea—Niacin—coronary artery disease	8.13e-05	0.000498	CcSEcCtD
Prazosin—Rash—Telmisartan—coronary artery disease	8.1e-05	0.000497	CcSEcCtD
Prazosin—Dermatitis—Telmisartan—coronary artery disease	8.1e-05	0.000496	CcSEcCtD
Prazosin—Diarrhoea—Furosemide—coronary artery disease	8.07e-05	0.000495	CcSEcCtD
Prazosin—Musculoskeletal discomfort—Lisinopril—coronary artery disease	8.06e-05	0.000494	CcSEcCtD
Prazosin—Pruritus—Losartan—coronary artery disease	8.05e-05	0.000494	CcSEcCtD
Prazosin—Headache—Telmisartan—coronary artery disease	8.05e-05	0.000494	CcSEcCtD
Prazosin—Feeling abnormal—Ramipril—coronary artery disease	8.04e-05	0.000493	CcSEcCtD
Prazosin—Dizziness—Perindopril—coronary artery disease	8.02e-05	0.000492	CcSEcCtD
Prazosin—Insomnia—Lisinopril—coronary artery disease	8e-05	0.000491	CcSEcCtD
Prazosin—Nausea—Pravastatin—coronary artery disease	8e-05	0.000491	CcSEcCtD
Prazosin—Paraesthesia—Lisinopril—coronary artery disease	7.95e-05	0.000487	CcSEcCtD
Prazosin—Vomiting—Captopril—coronary artery disease	7.95e-05	0.000487	CcSEcCtD
Prazosin—Dyspnoea—Lisinopril—coronary artery disease	7.89e-05	0.000484	CcSEcCtD
Prazosin—Rash—Captopril—coronary artery disease	7.88e-05	0.000483	CcSEcCtD
Prazosin—Dermatitis—Captopril—coronary artery disease	7.87e-05	0.000483	CcSEcCtD
Prazosin—Somnolence—Lisinopril—coronary artery disease	7.87e-05	0.000482	CcSEcCtD
Prazosin—Feeling abnormal—Timolol—coronary artery disease	7.86e-05	0.000482	CcSEcCtD
Prazosin—Headache—Captopril—coronary artery disease	7.83e-05	0.00048	CcSEcCtD
Prazosin—Dizziness—Furosemide—coronary artery disease	7.8e-05	0.000478	CcSEcCtD
Prazosin—Diarrhoea—Losartan—coronary artery disease	7.79e-05	0.000477	CcSEcCtD
Prazosin—Nausea—Trandolapril—coronary artery disease	7.77e-05	0.000476	CcSEcCtD
Prazosin—Urticaria—Ramipril—coronary artery disease	7.75e-05	0.000475	CcSEcCtD
Prazosin—Nausea—Enalapril—coronary artery disease	7.74e-05	0.000474	CcSEcCtD
Prazosin—Vomiting—Perindopril—coronary artery disease	7.71e-05	0.000473	CcSEcCtD
Prazosin—Body temperature increased—Ramipril—coronary artery disease	7.71e-05	0.000473	CcSEcCtD
Prazosin—Rash—Perindopril—coronary artery disease	7.65e-05	0.000469	CcSEcCtD
Prazosin—Dermatitis—Perindopril—coronary artery disease	7.64e-05	0.000469	CcSEcCtD
Prazosin—Nausea—Telmisartan—coronary artery disease	7.63e-05	0.000468	CcSEcCtD
Prazosin—Fatigue—Lisinopril—coronary artery disease	7.63e-05	0.000468	CcSEcCtD
Prazosin—Headache—Perindopril—coronary artery disease	7.6e-05	0.000466	CcSEcCtD
Prazosin—Urticaria—Timolol—coronary artery disease	7.58e-05	0.000465	CcSEcCtD
Prazosin—Pain—Lisinopril—coronary artery disease	7.57e-05	0.000464	CcSEcCtD
Prazosin—Constipation—Lisinopril—coronary artery disease	7.57e-05	0.000464	CcSEcCtD
Prazosin—Body temperature increased—Timolol—coronary artery disease	7.54e-05	0.000462	CcSEcCtD
Prazosin—Dizziness—Losartan—coronary artery disease	7.53e-05	0.000461	CcSEcCtD
Prazosin—Vomiting—Furosemide—coronary artery disease	7.5e-05	0.00046	CcSEcCtD
Prazosin—Rash—Furosemide—coronary artery disease	7.44e-05	0.000456	CcSEcCtD
Prazosin—Dermatitis—Furosemide—coronary artery disease	7.43e-05	0.000456	CcSEcCtD
Prazosin—Nausea—Captopril—coronary artery disease	7.42e-05	0.000455	CcSEcCtD
Prazosin—Headache—Furosemide—coronary artery disease	7.39e-05	0.000453	CcSEcCtD
Prazosin—Feeling abnormal—Lisinopril—coronary artery disease	7.29e-05	0.000447	CcSEcCtD
Prazosin—Vomiting—Losartan—coronary artery disease	7.24e-05	0.000444	CcSEcCtD
Prazosin—Nausea—Perindopril—coronary artery disease	7.21e-05	0.000442	CcSEcCtD
Prazosin—Hypersensitivity—Ramipril—coronary artery disease	7.19e-05	0.000441	CcSEcCtD
Prazosin—Rash—Losartan—coronary artery disease	7.18e-05	0.00044	CcSEcCtD
Prazosin—Dermatitis—Losartan—coronary artery disease	7.17e-05	0.00044	CcSEcCtD
Prazosin—Headache—Losartan—coronary artery disease	7.13e-05	0.000437	CcSEcCtD
Prazosin—Urticaria—Lisinopril—coronary artery disease	7.03e-05	0.000431	CcSEcCtD
Prazosin—Hypersensitivity—Timolol—coronary artery disease	7.03e-05	0.000431	CcSEcCtD
Prazosin—Nausea—Furosemide—coronary artery disease	7.01e-05	0.00043	CcSEcCtD
Prazosin—Asthenia—Ramipril—coronary artery disease	7e-05	0.000429	CcSEcCtD
Prazosin—Body temperature increased—Lisinopril—coronary artery disease	7e-05	0.000429	CcSEcCtD
Prazosin—Pruritus—Ramipril—coronary artery disease	6.9e-05	0.000423	CcSEcCtD
Prazosin—Asthenia—Timolol—coronary artery disease	6.84e-05	0.00042	CcSEcCtD
Prazosin—Nausea—Losartan—coronary artery disease	6.76e-05	0.000414	CcSEcCtD
Prazosin—Pruritus—Timolol—coronary artery disease	6.75e-05	0.000414	CcSEcCtD
Prazosin—Diarrhoea—Ramipril—coronary artery disease	6.68e-05	0.000409	CcSEcCtD
Prazosin—Diarrhoea—Timolol—coronary artery disease	6.53e-05	0.0004	CcSEcCtD
Prazosin—Hypersensitivity—Lisinopril—coronary artery disease	6.52e-05	0.0004	CcSEcCtD
Prazosin—Dizziness—Ramipril—coronary artery disease	6.45e-05	0.000396	CcSEcCtD
Prazosin—Asthenia—Lisinopril—coronary artery disease	6.35e-05	0.000389	CcSEcCtD
Prazosin—Dizziness—Timolol—coronary artery disease	6.31e-05	0.000387	CcSEcCtD
Prazosin—Pruritus—Lisinopril—coronary artery disease	6.26e-05	0.000384	CcSEcCtD
Prazosin—Vomiting—Ramipril—coronary artery disease	6.2e-05	0.00038	CcSEcCtD
Prazosin—Rash—Ramipril—coronary artery disease	6.15e-05	0.000377	CcSEcCtD
Prazosin—Dermatitis—Ramipril—coronary artery disease	6.15e-05	0.000377	CcSEcCtD
Prazosin—Headache—Ramipril—coronary artery disease	6.11e-05	0.000375	CcSEcCtD
Prazosin—Vomiting—Timolol—coronary artery disease	6.07e-05	0.000372	CcSEcCtD
Prazosin—Diarrhoea—Lisinopril—coronary artery disease	6.06e-05	0.000371	CcSEcCtD
Prazosin—Rash—Timolol—coronary artery disease	6.02e-05	0.000369	CcSEcCtD
Prazosin—Dermatitis—Timolol—coronary artery disease	6.01e-05	0.000368	CcSEcCtD
Prazosin—Headache—Timolol—coronary artery disease	5.98e-05	0.000366	CcSEcCtD
Prazosin—Dizziness—Lisinopril—coronary artery disease	5.85e-05	0.000359	CcSEcCtD
Prazosin—Nausea—Ramipril—coronary artery disease	5.8e-05	0.000355	CcSEcCtD
Prazosin—Nausea—Timolol—coronary artery disease	5.67e-05	0.000347	CcSEcCtD
Prazosin—Vomiting—Lisinopril—coronary artery disease	5.63e-05	0.000345	CcSEcCtD
Prazosin—Rash—Lisinopril—coronary artery disease	5.58e-05	0.000342	CcSEcCtD
Prazosin—Dermatitis—Lisinopril—coronary artery disease	5.58e-05	0.000342	CcSEcCtD
Prazosin—Headache—Lisinopril—coronary artery disease	5.54e-05	0.00034	CcSEcCtD
Prazosin—Nausea—Lisinopril—coronary artery disease	5.26e-05	0.000322	CcSEcCtD
Prazosin—Doxazosin—CYP2C19—coronary artery disease	3.55e-05	1	CrCbGaD
Prazosin—ADRA1B—Signaling Pathways—F2—coronary artery disease	2.25e-06	2.12e-05	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—GSK3B—coronary artery disease	2.25e-06	2.12e-05	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—IL6ST—coronary artery disease	2.25e-06	2.12e-05	CbGpPWpGaD
Prazosin—SLC22A2—Metabolism—NOS3—coronary artery disease	2.24e-06	2.11e-05	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—CXCL8—coronary artery disease	2.24e-06	2.11e-05	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—POMC—coronary artery disease	2.23e-06	2.11e-05	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—CREB1—coronary artery disease	2.23e-06	2.11e-05	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—NFKBIA—coronary artery disease	2.23e-06	2.1e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling by GPCR—CXCL8—coronary artery disease	2.22e-06	2.09e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—PPP2CA—coronary artery disease	2.21e-06	2.08e-05	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—MTHFR—coronary artery disease	2.19e-06	2.07e-05	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—FGF2—coronary artery disease	2.19e-06	2.06e-05	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—CCL2—coronary artery disease	2.19e-06	2.06e-05	CbGpPWpGaD
Prazosin—SLC22A1—Metabolism—ALB—coronary artery disease	2.18e-06	2.05e-05	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—IL6R—coronary artery disease	2.18e-06	2.05e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—HIF1A—coronary artery disease	2.18e-06	2.05e-05	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—GSK3B—coronary artery disease	2.17e-06	2.05e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—PRKCD—coronary artery disease	2.17e-06	2.04e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—AGT—coronary artery disease	2.17e-06	2.04e-05	CbGpPWpGaD
Prazosin—HTR1D—GPCR downstream signaling—AKT1—coronary artery disease	2.16e-06	2.04e-05	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—GSTP1—coronary artery disease	2.16e-06	2.03e-05	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—NOS3—coronary artery disease	2.16e-06	2.03e-05	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—KIT—coronary artery disease	2.16e-06	2.03e-05	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—POMC—coronary artery disease	2.16e-06	2.03e-05	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—CREB1—coronary artery disease	2.16e-06	2.03e-05	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—IGF1—coronary artery disease	2.15e-06	2.02e-05	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—CASP3—coronary artery disease	2.14e-06	2.02e-05	CbGpPWpGaD
Prazosin—ADRA2B—Signaling by GPCR—MAPK1—coronary artery disease	2.14e-06	2.02e-05	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—PPARGC1A—coronary artery disease	2.14e-06	2.01e-05	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—HMOX1—coronary artery disease	2.13e-06	2.01e-05	CbGpPWpGaD
Prazosin—HTR1D—Signaling by GPCR—IL6—coronary artery disease	2.13e-06	2e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—LEP—coronary artery disease	2.12e-06	2e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—APOE—coronary artery disease	2.12e-06	2e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—HTR2A—coronary artery disease	2.12e-06	2e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—C3—coronary artery disease	2.12e-06	2e-05	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—CCL2—coronary artery disease	2.11e-06	1.99e-05	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—IL6R—coronary artery disease	2.1e-06	1.98e-05	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—CAT—coronary artery disease	2.1e-06	1.98e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—APOA1—coronary artery disease	2.1e-06	1.98e-05	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—JAK2—coronary artery disease	2.1e-06	1.98e-05	CbGpPWpGaD
Prazosin—SLC22A1—Metabolism—NOS3—coronary artery disease	2.09e-06	1.97e-05	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—AGT—coronary artery disease	2.08e-06	1.96e-05	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—CCND1—coronary artery disease	2.08e-06	1.96e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—KDR—coronary artery disease	2.08e-06	1.96e-05	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—IGF1—coronary artery disease	2.07e-06	1.95e-05	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—GSK3B—coronary artery disease	2.07e-06	1.95e-05	CbGpPWpGaD
Prazosin—ABCG2—Metabolism—PTGS2—coronary artery disease	2.07e-06	1.95e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—MAPK14—coronary artery disease	2.07e-06	1.95e-05	CbGpPWpGaD
Prazosin—HTR1A—Signaling by GPCR—MAPK1—coronary artery disease	2.06e-06	1.95e-05	CbGpPWpGaD
Prazosin—ADRA1D—Signaling by GPCR—PIK3CA—coronary artery disease	2.06e-06	1.94e-05	CbGpPWpGaD
Prazosin—ADRA2A—Metabolism—PPARG—coronary artery disease	2.06e-06	1.94e-05	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—POMC—coronary artery disease	2.05e-06	1.94e-05	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—CREB1—coronary artery disease	2.05e-06	1.94e-05	CbGpPWpGaD
Prazosin—SLC22A2—Metabolism—PTGS2—coronary artery disease	2.05e-06	1.93e-05	CbGpPWpGaD
Prazosin—ADRA2B—GPCR downstream signaling—PIK3CA—coronary artery disease	2.04e-06	1.93e-05	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—APOE—coronary artery disease	2.04e-06	1.92e-05	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—SERPINE1—coronary artery disease	2.04e-06	1.92e-05	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—APOB—coronary artery disease	2.04e-06	1.92e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—ESR1—coronary artery disease	2.03e-06	1.91e-05	CbGpPWpGaD
Prazosin—ADRA2A—Metabolism—POMC—coronary artery disease	2.03e-06	1.91e-05	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—MMP9—coronary artery disease	2.02e-06	1.91e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—HIF1A—coronary artery disease	2.02e-06	1.9e-05	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—APOA1—coronary artery disease	2.02e-06	1.9e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—AGT—coronary artery disease	2.01e-06	1.9e-05	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—CCL2—coronary artery disease	2.01e-06	1.89e-05	CbGpPWpGaD
Prazosin—SLC22A3—Metabolism—PIK3CA—coronary artery disease	2.01e-06	1.89e-05	CbGpPWpGaD
Prazosin—ADRA2A—Hemostasis—AKT1—coronary artery disease	2e-06	1.89e-05	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—IL6R—coronary artery disease	2e-06	1.89e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—FN1—coronary artery disease	2e-06	1.89e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—F2—coronary artery disease	2e-06	1.89e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—IL6ST—coronary artery disease	1.99e-06	1.88e-05	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—GSTM1—coronary artery disease	1.98e-06	1.87e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—NFKBIA—coronary artery disease	1.98e-06	1.86e-05	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—IGF1—coronary artery disease	1.98e-06	1.86e-05	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—FGF2—coronary artery disease	1.98e-06	1.86e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—APOE—coronary artery disease	1.97e-06	1.86e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—LEP—coronary artery disease	1.97e-06	1.86e-05	CbGpPWpGaD
Prazosin—HTR1A—GPCR downstream signaling—PIK3CA—coronary artery disease	1.97e-06	1.86e-05	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—SERPINE1—coronary artery disease	1.97e-06	1.86e-05	CbGpPWpGaD
Prazosin—ADRA1B—Signaling by GPCR—MAPK1—coronary artery disease	1.97e-06	1.85e-05	CbGpPWpGaD
Prazosin—HTR1D—Signaling by GPCR—AKT1—coronary artery disease	1.96e-06	1.85e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—APOA1—coronary artery disease	1.95e-06	1.84e-05	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—NOS3—coronary artery disease	1.95e-06	1.84e-05	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—LPL—coronary artery disease	1.95e-06	1.83e-05	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	1.93e-06	1.82e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—KDR—coronary artery disease	1.93e-06	1.82e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—MAPK14—coronary artery disease	1.92e-06	1.81e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—KIT—coronary artery disease	1.92e-06	1.81e-05	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—CXCL8—coronary artery disease	1.91e-06	1.8e-05	CbGpPWpGaD
Prazosin—SLC22A1—Metabolism—PTGS2—coronary artery disease	1.91e-06	1.8e-05	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—FGF2—coronary artery disease	1.91e-06	1.8e-05	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—GPX1—coronary artery disease	1.9e-06	1.79e-05	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—JAK2—coronary artery disease	1.89e-06	1.78e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—ESR1—coronary artery disease	1.88e-06	1.77e-05	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—NOS3—coronary artery disease	1.88e-06	1.77e-05	CbGpPWpGaD
Prazosin—ADRA1B—GPCR downstream signaling—PIK3CA—coronary artery disease	1.88e-06	1.77e-05	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—SERPINE1—coronary artery disease	1.88e-06	1.77e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—FN1—coronary artery disease	1.86e-06	1.75e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—F2—coronary artery disease	1.86e-06	1.75e-05	CbGpPWpGaD
Prazosin—ADRA2B—Signaling by GPCR—PIK3CA—coronary artery disease	1.86e-06	1.75e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—IL6ST—coronary artery disease	1.85e-06	1.75e-05	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—CD36—coronary artery disease	1.85e-06	1.74e-05	CbGpPWpGaD
Prazosin—ADRA1D—GPCR downstream signaling—AKT1—coronary artery disease	1.85e-06	1.74e-05	CbGpPWpGaD
Prazosin—ADRA2A—Metabolism—ALB—coronary artery disease	1.85e-06	1.74e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—GSK3B—coronary artery disease	1.84e-06	1.73e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—NFKBIA—coronary artery disease	1.84e-06	1.73e-05	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—CASP3—coronary artery disease	1.83e-06	1.73e-05	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—JAK2—coronary artery disease	1.83e-06	1.72e-05	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—PPP2CA—coronary artery disease	1.83e-06	1.72e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—POMC—coronary artery disease	1.82e-06	1.72e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—CREB1—coronary artery disease	1.82e-06	1.72e-05	CbGpPWpGaD
Prazosin—ADRA1D—Signaling by GPCR—IL6—coronary artery disease	1.82e-06	1.72e-05	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—VEGFA—coronary artery disease	1.82e-06	1.71e-05	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—FGF2—coronary artery disease	1.82e-06	1.71e-05	CbGpPWpGaD
Prazosin—HTR1A—Signaling by GPCR—PIK3CA—coronary artery disease	1.79e-06	1.69e-05	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—NOS3—coronary artery disease	1.79e-06	1.69e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—CCL2—coronary artery disease	1.78e-06	1.68e-05	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—CCND1—coronary artery disease	1.78e-06	1.68e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—KIT—coronary artery disease	1.78e-06	1.68e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—IL6R—coronary artery disease	1.78e-06	1.68e-05	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—PPARG—coronary artery disease	1.78e-06	1.68e-05	CbGpPWpGaD
Prazosin—ADRA2A—Metabolism—NOS3—coronary artery disease	1.77e-06	1.67e-05	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—POMC—coronary artery disease	1.75e-06	1.65e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—IGF1—coronary artery disease	1.75e-06	1.65e-05	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—MTHFR—coronary artery disease	1.75e-06	1.65e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling by GPCR—MAPK1—coronary artery disease	1.75e-06	1.65e-05	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—JAK2—coronary artery disease	1.74e-06	1.64e-05	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—MMP9—coronary artery disease	1.73e-06	1.63e-05	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—CXCL8—coronary artery disease	1.73e-06	1.63e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—GSK3B—coronary artery disease	1.71e-06	1.61e-05	CbGpPWpGaD
Prazosin—ADRA1B—Signaling by GPCR—PIK3CA—coronary artery disease	1.71e-06	1.61e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—CREB1—coronary artery disease	1.69e-06	1.6e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—POMC—coronary artery disease	1.69e-06	1.6e-05	CbGpPWpGaD
Prazosin—ADRA1D—Signaling by GPCR—AKT1—coronary artery disease	1.68e-06	1.58e-05	CbGpPWpGaD
Prazosin—ADRA2B—GPCR downstream signaling—AKT1—coronary artery disease	1.67e-06	1.57e-05	CbGpPWpGaD
Prazosin—ADRA1A—GPCR downstream signaling—PIK3CA—coronary artery disease	1.67e-06	1.57e-05	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—CXCL8—coronary artery disease	1.67e-06	1.57e-05	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—TGFB1—coronary artery disease	1.67e-06	1.57e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—SERPINE1—coronary artery disease	1.67e-06	1.57e-05	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—AGT—coronary artery disease	1.67e-06	1.57e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—CCL2—coronary artery disease	1.66e-06	1.56e-05	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—CASP3—coronary artery disease	1.65e-06	1.56e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—IL6R—coronary artery disease	1.65e-06	1.56e-05	CbGpPWpGaD
Prazosin—ADRA2B—Signaling by GPCR—IL6—coronary artery disease	1.64e-06	1.55e-05	CbGpPWpGaD
Prazosin—SLC22A3—Metabolism—AKT1—coronary artery disease	1.64e-06	1.55e-05	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—MAPK1—coronary artery disease	1.63e-06	1.54e-05	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—APOE—coronary artery disease	1.63e-06	1.54e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—IGF1—coronary artery disease	1.63e-06	1.54e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling by GPCR—MAPK1—coronary artery disease	1.62e-06	1.53e-05	CbGpPWpGaD
Prazosin—ADRA2A—Metabolism—PTGS2—coronary artery disease	1.62e-06	1.52e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—FGF2—coronary artery disease	1.61e-06	1.52e-05	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—APOA1—coronary artery disease	1.61e-06	1.52e-05	CbGpPWpGaD
Prazosin—HTR1A—GPCR downstream signaling—AKT1—coronary artery disease	1.61e-06	1.52e-05	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—CCND1—coronary artery disease	1.61e-06	1.52e-05	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—ALB—coronary artery disease	1.6e-06	1.51e-05	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—CASP3—coronary artery disease	1.6e-06	1.5e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—NOS3—coronary artery disease	1.59e-06	1.5e-05	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—CXCL8—coronary artery disease	1.59e-06	1.5e-05	CbGpPWpGaD
Prazosin—HTR1A—Signaling by GPCR—IL6—coronary artery disease	1.59e-06	1.49e-05	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—MMP9—coronary artery disease	1.56e-06	1.47e-05	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—VEGFA—coronary artery disease	1.55e-06	1.46e-05	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—CCND1—coronary artery disease	1.55e-06	1.46e-05	CbGpPWpGaD
Prazosin—ADRA2A—GPCR downstream signaling—PIK3CA—coronary artery disease	1.55e-06	1.46e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—SERPINE1—coronary artery disease	1.55e-06	1.46e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—JAK2—coronary artery disease	1.55e-06	1.46e-05	CbGpPWpGaD
Prazosin—ADRA1B—GPCR downstream signaling—AKT1—coronary artery disease	1.53e-06	1.45e-05	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—NOS3—coronary artery disease	1.53e-06	1.44e-05	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—CASP3—coronary artery disease	1.52e-06	1.43e-05	CbGpPWpGaD
Prazosin—ADRA2B—Signaling by GPCR—AKT1—coronary artery disease	1.52e-06	1.43e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling by GPCR—PIK3CA—coronary artery disease	1.52e-06	1.43e-05	CbGpPWpGaD
Prazosin—ADRA1B—Signaling by GPCR—IL6—coronary artery disease	1.51e-06	1.42e-05	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—MMP9—coronary artery disease	1.51e-06	1.42e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—FGF2—coronary artery disease	1.5e-06	1.41e-05	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—CCND1—coronary artery disease	1.48e-06	1.39e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—NOS3—coronary artery disease	1.48e-06	1.39e-05	CbGpPWpGaD
Prazosin—HTR1A—Signaling by GPCR—AKT1—coronary artery disease	1.46e-06	1.38e-05	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—MMP9—coronary artery disease	1.44e-06	1.35e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—JAK2—coronary artery disease	1.44e-06	1.35e-05	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—TGFB1—coronary artery disease	1.43e-06	1.34e-05	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—PPARG—coronary artery disease	1.42e-06	1.34e-05	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—PIK3CA—coronary artery disease	1.42e-06	1.34e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—CXCL8—coronary artery disease	1.41e-06	1.33e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling by GPCR—PIK3CA—coronary artery disease	1.41e-06	1.33e-05	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—VEGFA—coronary artery disease	1.4e-06	1.32e-05	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—POMC—coronary artery disease	1.4e-06	1.32e-05	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—PTGS2—coronary artery disease	1.4e-06	1.32e-05	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—MAPK1—coronary artery disease	1.4e-06	1.32e-05	CbGpPWpGaD
Prazosin—ADRA1B—Signaling by GPCR—AKT1—coronary artery disease	1.39e-06	1.31e-05	CbGpPWpGaD
Prazosin—ADRA1A—GPCR downstream signaling—AKT1—coronary artery disease	1.36e-06	1.28e-05	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—VEGFA—coronary artery disease	1.35e-06	1.28e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—CASP3—coronary artery disease	1.35e-06	1.27e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling by GPCR—IL6—coronary artery disease	1.34e-06	1.26e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—CCND1—coronary artery disease	1.31e-06	1.24e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—CXCL8—coronary artery disease	1.31e-06	1.24e-05	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—VEGFA—coronary artery disease	1.29e-06	1.22e-05	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—TGFB1—coronary artery disease	1.29e-06	1.21e-05	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—ALB—coronary artery disease	1.28e-06	1.2e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—MMP9—coronary artery disease	1.28e-06	1.2e-05	CbGpPWpGaD
Prazosin—ABCG2—Metabolism—PIK3CA—coronary artery disease	1.27e-06	1.2e-05	CbGpPWpGaD
Prazosin—ADRA2A—GPCR downstream signaling—AKT1—coronary artery disease	1.27e-06	1.19e-05	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—MAPK1—coronary artery disease	1.26e-06	1.19e-05	CbGpPWpGaD
Prazosin—SLC22A2—Metabolism—PIK3CA—coronary artery disease	1.26e-06	1.19e-05	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—IL6—coronary artery disease	1.26e-06	1.18e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—CASP3—coronary artery disease	1.25e-06	1.18e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling by GPCR—IL6—coronary artery disease	1.25e-06	1.17e-05	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—TGFB1—coronary artery disease	1.24e-06	1.17e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling by GPCR—AKT1—coronary artery disease	1.24e-06	1.17e-05	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—NOS3—coronary artery disease	1.22e-06	1.15e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—CCND1—coronary artery disease	1.22e-06	1.15e-05	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—MAPK1—coronary artery disease	1.22e-06	1.15e-05	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—PIK3CA—coronary artery disease	1.21e-06	1.14e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—MMP9—coronary artery disease	1.19e-06	1.12e-05	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—TGFB1—coronary artery disease	1.18e-06	1.12e-05	CbGpPWpGaD
Prazosin—SLC22A1—Metabolism—PIK3CA—coronary artery disease	1.17e-06	1.11e-05	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—MAPK1—coronary artery disease	1.16e-06	1.09e-05	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—AKT1—coronary artery disease	1.16e-06	1.09e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling by GPCR—AKT1—coronary artery disease	1.15e-06	1.08e-05	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—VEGFA—coronary artery disease	1.15e-06	1.08e-05	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—PTGS2—coronary artery disease	1.12e-06	1.05e-05	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—PIK3CA—coronary artery disease	1.1e-06	1.03e-05	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—IL6—coronary artery disease	1.08e-06	1.01e-05	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—VEGFA—coronary artery disease	1.06e-06	1e-05	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—PIK3CA—coronary artery disease	1.06e-06	9.97e-06	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—TGFB1—coronary artery disease	1.05e-06	9.91e-06	CbGpPWpGaD
Prazosin—ABCG2—Metabolism—AKT1—coronary artery disease	1.04e-06	9.79e-06	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—MAPK1—coronary artery disease	1.03e-06	9.72e-06	CbGpPWpGaD
Prazosin—SLC22A2—Metabolism—AKT1—coronary artery disease	1.03e-06	9.69e-06	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—PIK3CA—coronary artery disease	1.01e-06	9.5e-06	CbGpPWpGaD
Prazosin—ADRA2A—Metabolism—PIK3CA—coronary artery disease	9.95e-07	9.37e-06	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—AKT1—coronary artery disease	9.92e-07	9.35e-06	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—TGFB1—coronary artery disease	9.77e-07	9.21e-06	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—IL6—coronary artery disease	9.71e-07	9.15e-06	CbGpPWpGaD
Prazosin—SLC22A1—Metabolism—AKT1—coronary artery disease	9.59e-07	9.03e-06	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—MAPK1—coronary artery disease	9.58e-07	9.03e-06	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—IL6—coronary artery disease	9.37e-07	8.83e-06	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—AKT1—coronary artery disease	8.96e-07	8.44e-06	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—PIK3CA—coronary artery disease	8.95e-07	8.44e-06	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—IL6—coronary artery disease	8.92e-07	8.41e-06	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—AKT1—coronary artery disease	8.64e-07	8.15e-06	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—PIK3CA—coronary artery disease	8.61e-07	8.11e-06	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—PIK3CA—coronary artery disease	8.32e-07	7.84e-06	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—AKT1—coronary artery disease	8.23e-07	7.76e-06	CbGpPWpGaD
Prazosin—ADRA2A—Metabolism—AKT1—coronary artery disease	8.13e-07	7.66e-06	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—IL6—coronary artery disease	7.93e-07	7.47e-06	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—IL6—coronary artery disease	7.36e-07	6.94e-06	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—AKT1—coronary artery disease	7.31e-07	6.89e-06	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—AKT1—coronary artery disease	7.03e-07	6.63e-06	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—PIK3CA—coronary artery disease	6.88e-07	6.48e-06	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—AKT1—coronary artery disease	6.79e-07	6.4e-06	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—AKT1—coronary artery disease	5.62e-07	5.29e-06	CbGpPWpGaD
